4K® score test in the time of COVID-19 quarantine -
implications for timely diagnosis of high-risk prostate cancer
Friedman Boris1,Neuberger Ami2,
Ephrat Omer1, Manaster Yoav3,
Freifeld Yuval1, Dekel Yoram1
1- Urology Department, Carmel Lady Davis medical center, Haifa, Israel
2 - Infectious Disease Department, Rambam Health care Campus, Haifa,
Israel
3 - Progenetics company LTD
Friedman Boris –
friedmanboris173@gmail.com
Neuberger Ami –
a_neuberger@rambam.health.gov.il
Ephrat Omer –
omerephratmed@gmail.com
Manaster Yoav –
yoav@progenetics.co.il
Freifeld Yuval –
yuvalfr@clalit.org.il
Dekel Yoram -
yoramd@clalit.org.il